MedTrace Logo

Expression of Erythroid Differentiation Regulator 1 (Erdr1) in Vitiligo

NCT03377998 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2017-12-19

No results posted yet for this study

Summary

Expression of Erythroid differentiation regulator 1 (Erdr1) cytokine in vitiligo

Conditions

  • Erythroid Differentiation Regulator 1 (Erdr1) Cytokine

Interventions

OTHER

skin biopsy

Skin biopsy for measuring tissue levels of the Erythroid differentiation regulator 1 (Erdr1) cytokine will be taken from the lesional skin of patients of vitiligo and from normal skin of healthy controls.

Sponsors & Collaborators

  • Cairo University

    lead OTHER

Principal Investigators

  • Maha Elmasry, MD · Cairo University

Study Design

Allocation
NON_RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-01-31
Primary Completion
2018-07-31
Completion
2018-07-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03377998 on ClinicalTrials.gov